...
首页> 外文期刊>Genetics research international >Molecular Alterations in Sporadic Primary Hyperparathyroidism
【24h】

Molecular Alterations in Sporadic Primary Hyperparathyroidism

机译:散发性原发性甲状旁腺功能亢进症的分子改变

获取原文
           

摘要

Primary hyperparathyroidism (PHPT) is a frequent endocrine disorder characterized by an excessive autonomous production and release of parathyroid hormone (PTH) by the parathyroid glands. This endocrinopathy may result from the development of a benign lesion (adenoma or hyperplasia) or from a carcinoma. Most of the PHPT cases occur sporadically; however, approximately 10% of the patients present a familial form of the disease. The molecular mechanisms underlying the pathogenesis of sporadic PHPT are incompletely understood, even though somatic alterations inMEN1gene and CCND1 protein overexpression are frequently observed. TheMEN1gene is mutated in about 30% of the parathyroid tumours and the protooncogeneCCND1is implicated in parathyroid neoplasia by rearrangements, leading to an overexpression of CCND1 protein in parathyroid cells. The aim of this work is to briefly update the molecular alterations underlying sporadic primary hyperparathyroidism.
机译:原发性甲状旁腺功能亢进症(PHPT)是一种常见的内分泌疾病,其特征是甲状旁腺过度自主产生和释放甲状旁腺激素(PTH)。这种内分泌病变可能是由于良性病变(腺瘤或增生)的发展或癌变引起的。大多数PHPT案件都是零星发生的。但是,约有10%的患者表现出该疾病的家族形式。尽管经常观察到MEN1基因和CCND1蛋白过表达的体细胞改变,但零星PHPT发病机理的分子机制仍未得到完全理解。 MEN1基因在约30%的甲状旁腺肿瘤中发生突变,原癌基因CCND1通过重排参与甲状旁腺肿瘤,导致甲状旁腺细胞中CCND1蛋白过表达。这项工作的目的是简要地更新散发性原发性甲状旁腺功能亢进症的分子改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号